<p>rhTPO combined with chemotherapy and G-CSF for autologous peripheral blood stem cells in patients with refractory/relapsed non-Hodgkin’s lymphoma</p>
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.